# North America Cosmetic Surgery Market

> North America Cosmetic Surgery Market Research Report Information By Procedure (Surgical Procedures and Non-surgical Procedures), By Gender (Female and Male), By Age Group (18 years and younger, 19 to 34 years, 35 to 50 years, 51 to 64 years and 65 years & above), By Provider (Hospitals & Specialty Clinics and Spas & Cosmetic Surgery Centers) –and North America Market Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.68%
- **2024:** $ 21.5 Billion
- **2025:** $ 23.15 Billion
- **2035:** $ 48.5 Billion
- **Key Players:** Allergan (US), Galderma(CH), Revance Therapeutics (US), Medytox (KR), Hugel (KR), Ipsen (FR), Medytox (KR), Sientra (US), Croma-Pharma (AT)

**Report ID:** MRFR/HC/14649-HCR · **Pages:** 128 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/north-america-cosmetic-surgery-market-16176

---

## Market Summary

## **North America Cosmetic Surgery Market Overview**

As per MRFR analysis, the North America Cosmetic Surgery Market Size was estimated at 20.20 (USD Billion) in 2024. The North America Cosmetic Surgery Market Industry is expected to grow from 21.11 (USD Billion) in 2025 to 31.38 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.50% during the forecast period (2025 - 2034). The growing awareness about available cosmetic procedures is one of the major market drivers driving the Cosmetic Surgery market in North America. Industries are adopting Cosmetic Surgery due to improved accessibility to cosmetic surgery clinics.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **North America Cosmetic Surgery Market Trends**

### **Growing popularity of non-invasive procedures is driving the market growth**

The North American Cosmetic Surgery market CAGR is expanding due to the growing popularity of non-invasive procedures. Patients are increasingly seeking less invasive alternatives to traditional surgical interventions, driven by factors such as reduced downtime, fewer complications, and a desire for subtle enhancements. Non-invasive procedures, including injectables like Botox and [dermal fillers](../../../reports/dermal-fillers-market-3893), laser treatments, and chemical peels, are gaining traction due to their convenience and quicker recovery times. Technology advancements have played a major role in developing these non-surgical options, offering patients effective solutions with minimal disruption to their daily lives.

Furthermore, the growth of the Cosmetic Surgery market is influenced by technology. Innovations such as 3D imaging, virtual reality, and artificial intelligence are incorporated into various aspects of cosmetic surgery. Surgeons use 3D imaging to provide more accurate simulations of potential outcomes, allowing patients to visualize results before a procedure. Virtual reality is being utilized for training purposes and patient education. Additionally, artificial intelligence aids in personalized treatment plans, improving surgical precision and enhancing post-operative care. These technological advancements contribute to improved patient experiences and drive the efficiency and effectiveness of cosmetic procedures. Thus driving the Cosmetic Surgery market revenue.

## **North America Cosmetic Surgery Market Segment Insights**

### **Cosmetic Surgery Procedure Insights**

The North America Cosmetic Surgery market segmentation is based on Surgical procedures and Non-surgical procedures. The surgical procedures segment mostly dominated the market. The surgical procedures, such as [breast augmentation](../../../reports/breast-reconstruction-augmentation-market-7263), liposuction, rhinoplasty, and facelifts, dominate this segment. Increasing demand for aesthetic enhancements and advancements in surgical techniques contribute to the market's growth, reflecting a thriving landscape for surgical cosmetic interventions in North America.

**Figure 1: North America Cosmetic Surgery Market, by Procedure, 2022 & 2032 (USD Billion)**

****

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Cosmetic Surgery Gender Insights**

 The North America Cosmetic Surgery market segmentation, based on gender, includes Females and Males. The females category generated the most income. With a growing trend in aesthetic procedures, North American women are seeking various cosmetic enhancements to achieve desired beauty standards and boost self-confidence. The market caters to diverse procedures catering specifically to the female.

### **Cosmetic Surgery Age Group Insights**

The North America Cosmetic Surgery market segmentation, based on age group, includes 18 years & younger, 19 to 34 years, 35 to 50 years, 51 to 64 years, and 65 years & above. The 35 to 50 years category generated the most income. This demographic will likely seek cosmetic procedures to address aging concerns and enhance appearance. Procedures such as facelifts, Botox injections, and body contouring may be popular within this age bracket, reflecting a growing demand for aesthetic enhancements among individuals in their mid-thirties to fifties.

### **Cosmetic Surgery Provider Insights**

The North America Cosmetic Surgery market segmentation, based on provider, includes Hospitals, specialty Clinics, and spa and cosmetic Surgery Centers. The hospitals & specialty clinics category generated the most income. Hospitals offer a comprehensive range of surgical procedures focusing on medical care, while specialty clinics specialize in cosmetic and aesthetic treatments. This segmentation caters to diverse patient needs, providing options for both medical and elective procedures in the dynamic North American cosmetic surgery landscape.

### **Cosmetic Surgery Country Insights**

The rapid expansion of the healthcare infrastructure has resulted in a recent boom in demand for Cosmetic Surgery in North America. In the United States, the largest market in the region, cosmetic procedures like breast augmentation, liposuction, and Botox injections remain popular. The country's advanced healthcare infrastructure and increasing aesthetic consciousness drive market growth. Canada witnesses a surge in demand for non-invasive procedures, such as laser and dermal treatments, focusing on natural-looking results. Mexico, a burgeoning market, attracts medical tourists seeking affordable yet high-quality cosmetic surgeries.

The North American cosmetic surgery market is characterized by technological advancements, a rise in the aging population, and a cultural emphasis on beauty standards, fostering continuous innovation and expansion in the aesthetic industry across the region.

**Figure 2: NORTH AMERICA Cosmetic Surgery MARKET SHARE BY REGION 2022 (USD Billion)**

****

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Cosmetic Surgery Key Market Players & Competitive Insights**

Leading market players are investing majorly in research and development to spread their product lines, which will help the Cosmetic Surgery market grow even more. The participants are also undertaking various strategic activities to spread their footprint with new market developments, including product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. The Cosmetic Surgery industry must offer cost-effective items to spread and survive in a competitive and rising market climate.

Major players in the Cosmetic Surgery market are attempting to raise market demand by investing in research and development operations, including Bausch Health Companies Inc. (Canada), Johnson & Johnson Services, Inc. (MENTOR) (U.S.), AbbVie Inc. (U.S.), Cutera (U.S.), Merz Pharma (Germany), GALDERMA (Switzerland), Sientra, Inc. (U.S.), Cynosure (U.S.), Apyx Medical (U.S.) and Long Island Plastic Surgical Group, PC (U.S.).

### **Key Companies in the Cosmetic Surgery market include**

- Bausch Health Companies Inc. (Canada)
- Johnson & Johnson Services, Inc. (MENTOR) (U.S.)
- [AbbVie Inc.](https://www.abbvie.com/patients/products.html) (U.S.)
- [Cutera](https://cutera.com/us-en/products/aviclear/) (U.S.)
- Merz Pharma (Germany)
- GALDERMA (Switzerland)
- Sientra, Inc. (U.S.)
- Cynosure (U.S.)
- Apyx Medical (U.S.)
- Long Island Plastic Surgical Group, PC (U.S.)

## North America Cosmetic Surgery Industry Developments

- **Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults** Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid microdroplet injectable, for improving cheek skin smoothness in adults in the United States.
- **Q2 2024: Cutera Appoints Taylor Harris as Chief Executive Officer** Cutera, Inc., a provider of aesthetic and dermatology solutions, announced the appointment of Taylor Harris as its new Chief Executive Officer, effective May 2024.
- **Q2 2024: Revance Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia** Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its neuromodulator portfolio in the U.S. market.
- **Q1 2024: Sientra Announces FDA Approval of New Breast Implant Manufacturing Facility in Wisconsin** Sientra, Inc. received FDA approval for its new breast implant manufacturing facility in Wisconsin, aiming to increase production capacity and meet growing demand in the North American cosmetic surgery market.
- **Q1 2024: Alastin Skincare Launches New Procedure Enhancement System for Post-Cosmetic Surgery Recovery** Alastin Skincare, a Galderma company, launched a new Procedure Enhancement System designed to support post-cosmetic surgery recovery, targeting clinics and patients in North America.
- **Q2 2024: Allergan Aesthetics Launches JUVÉDERM® VOLUX™ XC for Jawline Enhancement in the U.S.** Allergan Aesthetics announced the U.S. launch of JUVÉDERM® VOLUX™ XC, a hyaluronic acid-based injectable gel for jawline enhancement, expanding its facial aesthetics portfolio.
- **Q2 2024: Cutera Launches AviClear™ Acne Device in North America** Cutera, Inc. launched AviClear™, a new energy-based device for the treatment of mild to severe acne, in North America, targeting dermatology and cosmetic surgery clinics.
- **Q1 2024: Galderma Announces U.S. FDA Approval of Restylane® Eyelight for the Treatment of Undereye Hollows** Galderma received FDA approval for Restylane® Eyelight, a hyaluronic acid filler for the treatment of undereye hollows, expanding its injectable product offerings in the U.S.
- **Q2 2024: Soliton, Inc. Announces Partnership with Aesthetic Solutions for Rapid Acoustic Pulse Technology** Soliton, Inc. entered into a partnership with Aesthetic Solutions to distribute its Rapid Acoustic Pulse technology for cellulite and tattoo removal in North America.
- **Q1 2024: Venus Concept Announces FDA Clearance of Venus Bliss Max™ for Non-Invasive Lipolysis** Venus Concept received FDA clearance for Venus Bliss Max™, a new device for non-invasive lipolysis of the abdomen and flanks, targeting cosmetic surgery providers in North America.
- **Q2 2024: InMode Ltd. Launches EmpowerRF Platform for Women’s Health and Wellness in the U.S.** InMode Ltd. launched EmpowerRF, a new platform for women’s health and wellness procedures, including minimally invasive cosmetic treatments, in the U.S. market.
- **Q1 2024: Apyx Medical Receives FDA 510(k) Clearance for Renuvion® APR Handpiece for Dermal Resurfacing** Apyx Medical Corporation received FDA 510(k) clearance for its Renuvion® APR Handpiece, expanding its portfolio of devices for dermal resurfacing procedures in the U.S.

## **Cosmetic Surgery Market Segmentation**

### **Cosmetic Surgery Procedure Outlook**

- Surgical Procedures
- Non-Surgical Procedures

### **Cosmetic Surgery Gender Outlook**

- Female
- Male

### **Cosmetic Surgery Age Group Outlook**

- 18 years & younger
- 19 to 34 years
- 35 to 50 years
- 51 to 64 years
- 65 years & above

### **Cosmetic Surgery Provider Outlook**

- Hospitals & Specialty Clinics
- Spas & Cosmetic Surgery Centers

### **Cosmetic Surgery Regional Outlook**

## Market Drivers

### Influence of Aging Population

The aging population in North America serves as a pivotal driver for the cosmetic surgery market. As the demographic landscape shifts, a larger segment of the population is seeking cosmetic procedures to address age-related concerns. Reports indicate that individuals aged 50 and above account for nearly 40% of all cosmetic surgeries performed, highlighting the demand for anti-aging treatments. This trend is likely to persist as the baby boomer generation continues to age, with many individuals desiring to maintain a youthful appearance. The increasing focus on health and wellness among older adults further amplifies this demand, as they seek procedures that enhance their quality of life. Consequently, the cosmetic surgery market is expected to adapt and expand its offerings to cater to this growing demographic, ensuring that it meets the evolving needs of an aging clientele.

### Expansion of Non-Surgical Options

The expansion of non-surgical options within the cosmetic surgery market is a notable trend that is reshaping consumer preferences. Treatments such as injectables, fillers, and skin rejuvenation procedures have gained immense popularity due to their minimal downtime and lower costs compared to traditional surgical options. Recent statistics reveal that non-surgical procedures now account for over 60% of the total cosmetic procedures performed, indicating a significant shift in consumer choice. This trend is particularly appealing to younger demographics who may be hesitant to undergo invasive surgeries. As practitioners continue to innovate and improve non-surgical offerings, the market is likely to see sustained growth. The increasing availability and acceptance of these alternatives suggest that the cosmetic surgery market will continue to evolve, catering to a broader audience seeking effective yet less invasive solutions.

### Increasing Acceptance of Cosmetic Procedures

The growing acceptance of cosmetic procedures among various demographics is a notable driver in the cosmetic surgery market. As societal norms evolve, more individuals view cosmetic enhancements as a means of self-improvement rather than vanity. This shift is particularly evident among younger generations, with a reported increase of 30% in procedures among individuals aged 18-34 in recent years. The normalization of cosmetic surgery through media representation and celebrity endorsements further contributes to this trend. As acceptance rises, the market is likely to expand, with more individuals seeking surgical and non-surgical options to enhance their appearance. This cultural shift not only influences consumer behavior but also encourages practitioners to innovate and diversify their offerings, thereby stimulating growth in the cosmetic surgery market.

### Rising Disposable Income and Consumer Spending

The increase in disposable income among consumers in North America is a significant driver of the cosmetic surgery market. As individuals experience higher earnings, they are more inclined to invest in personal aesthetics. Recent data indicates that consumer spending on cosmetic procedures has risen by approximately 15% over the past few years, reflecting a growing willingness to allocate funds towards enhancing one's appearance. This trend is particularly pronounced among middle to upper-income brackets, where individuals prioritize self-care and personal image. The correlation between economic prosperity and spending on cosmetic enhancements suggests that as the economy continues to improve, the cosmetic surgery market may experience sustained growth. This financial empowerment allows consumers to explore a wider range of options, further fueling demand for various cosmetic procedures.

### Technological Advancements in Surgical Techniques

Technological advancements play a crucial role in shaping the cosmetic surgery market. Innovations such as 3D imaging, robotic-assisted surgery, and minimally invasive techniques have transformed the landscape of cosmetic procedures. These advancements not only enhance the precision and safety of surgeries but also reduce recovery times, making procedures more appealing to potential clients. For instance, the introduction of laser technology has led to a 25% increase in the popularity of skin resurfacing treatments. As technology continues to evolve, it is expected that the market will witness further growth, with new techniques emerging that cater to the demands of a more informed and discerning clientele. This ongoing evolution in surgical technology is likely to drive competition among practitioners, ultimately benefiting consumers in the cosmetic surgery market.

## Future Outlook

The cosmetic surgery market is projected to grow at a 7.68% CAGR from 2025 to 2035, driven by technological advancements, increasing consumer awareness, and rising disposable incomes.

**New opportunities:**

- Expansion of [telemedicine](https://www.marketresearchfuture.com/reports/telemedicine-market-2216)consultations for pre-surgery assessments. Development of minimally invasive procedures to attract younger demographics. Partnerships with wellness brands for bundled service offerings.

By 2035, the market is expected to be robust, driven by innovation and evolving consumer preferences.

## Segment Insights

### By Procedure Type: Invasive (Largest) vs. Non-Invasive (Fastest-Growing)

In the North America cosmetic surgery market, the invasive procedure segment currently holds the largest share, as it encompasses a wide range of established surgical options, such as liposuction and breast augmentation. These procedures have continued to dominate consumer preferences due to their lasting results and effectiveness. On the other hand, non-invasive procedures are rapidly gaining ground, appealing particularly to younger demographics seeking less invasive options. As awareness grows, the distribution of market share is shifting towards non-invasive procedures, highlighting a significant change in consumer behavior.

The growth trends for these two segments illustrate a fascinating dichotomy in consumer choice. The invasive segment benefits from a long-standing reputation and proven results, fostering trust among patients. However, the non-invasive realm is becoming increasingly attractive due to technological advancements, lower recovery times, and enhanced safety profiles. As more consumers prioritize convenience and minimal downtime, this emerging segment is set to expand swiftly, with innovative treatment options likely to drive further growth in the coming years.

Invasive (Dominant) vs. Non-Invasive (Emerging)

Invasive procedures are characterized by surgical techniques that require incisions, leading to more significant alterations in appearance, which some consumers prefer for long-lasting results. This segment is viewed as dominant due to its established reputation and the comprehensive nature of the procedures involved. On the other hand, non-invasive procedures, which utilize techniques such as injectables and laser treatments, are categorized as emerging due to their rising popularity. They offer a safer, less painful alternative with quicker recovery times, appealing especially to younger adults. The shift toward non-invasive options highlights evolving consumer preferences, driven by a desire for effective yet minimally invasive treatments, making this segment a key player in future market dynamics.

### By End User: Hospitals and Dermatology Clinics (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The market share distribution in the End User segment reveals that Hospitals and Dermatology Clinics hold a substantial majority, catering to a wide range of cosmetic surgery needs with their advanced facilities and specialized staff. In contrast, Ambulatory Surgical Centers are emerging as pivotal players, providing less complex surgeries and benefiting from lower operational costs, which makes them an attractive option for patients seeking efficiency and convenience.

Growth trends indicate that Ambulatory Surgical Centers are experiencing rapid expansion, driven by increased consumer demand for outpatient procedures and advances in minimally invasive techniques. This shift is further bolstered by rising health consciousness among the population and changes in insurance policies that support outpatient treatments, positioning these centers as a preferred choice for many individuals seeking cosmetic enhancements.

Hospitals and Dermatology Clinics (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals and Dermatology Clinics dominate the End User segment due to their comprehensive care capabilities and specialization in cosmetic procedures. These establishments not only offer an extensive range of surgical and non-surgical treatments but also ensure high-quality standards and patient safety. They have established reputations that attract a diverse patient base looking for reassurance and expertise. On the other hand, Ambulatory Surgical Centers represent an emerging force in the market, known for their focus on outpatient procedures. They provide a more patient-friendly environment with lower costs and reduced recovery times, appealing to a younger demographic and those seeking quick results without the need for hospital admissions. This evolving dynamic between traditional and emerging centers is shaping the future landscape of cosmetic surgery.

### By Age Group: 19 to 34 years (Largest) vs. 35 to 50 years (Fastest-Growing)

In the North America Cosmetic Surgery Market, the age distribution indicates that individuals aged 19 to 34 years hold the largest market share, representing a significant portion of the cosmetic surgery demographic. This age group is notably enthusiastic about aesthetic enhancements, significantly influencing the trends and preferences within the market. Conversely, the 35 to 50 years segment is emerging as the fastest-growing, as more individuals within this age range seek procedures aimed at rejuvenation and enhancing their appearance, particularly driven by cultural shifts towards self-care and the normalization of cosmetic solutions.

19 to 34 years (Dominant) vs. 35 to 50 years (Emerging)

The 19 to 34 years age group is characterized by a propensity for cosmetic surgeries that cater to contemporary beauty standards shaped by social media influences. This demographic often opts for minimally invasive procedures, including fillers and laser treatments, focused on enhancing their features with subtlety. Meanwhile, the 35 to 50 years segment is increasingly gaining traction, focusing on procedures that emphasize anti-aging benefits. Individuals in this cohort seek surgical and non-surgical treatments that provide significant results, driving their rapid growth. The blend of innovation in cosmetic techniques and the growing acceptance of cosmetic enhancements among older adults positions this age group as a key player in the market.

### By Provider: Hospitals & Specialty Clinics (Largest) vs. Spas & Cosmetic Surgery Centers (Fastest-Growing)

The North America Cosmetic Surgery Market exhibits a notable distribution of market share among its provider segments. Hospitals and specialty clinics hold the largest share, primarily due to their established reputation and comprehensive service offerings. These facilities typically provide a wide range of cosmetic procedures, backed by qualified medical professionals, thus instilling confidence in prospective patients. Meanwhile, spas and cosmetic surgery centers are rapidly gaining traction, reflecting an increasing consumer preference for less invasive procedures and aesthetic enhancements in a more relaxed setting.

Growth trends in the provider segment are significantly influenced by evolving consumer attitudes towards cosmetic procedures. The trend towards minimally invasive and non-surgical options has propelled spas and cosmetic surgery centers to the forefront, attracting a younger demographic. Moreover, marketing strategies emphasizing luxury experiences and personalized services are enabling these centers to rapidly expand their clientele. As such, while hospitals and specialty clinics maintain dominance, the dynamic growth of the spa segment indicates shifting consumer preferences and an evolving market landscape.

Hospitals & Specialty Clinics (Dominant) vs. Spas & Cosmetic Surgery Centers (Emerging)

Hospitals and specialty clinics represent the dominant force in the North America Cosmetic Surgery Market, renowned for their extensive surgical capabilities and stringent safety standards. They offer a comprehensive array of procedures and boast highly trained professionals, making them the preferred choice for patients seeking serious cosmetic surgeries. Conversely, spas and cosmetic surgery centers are emerging players, appealing to consumers with a growing interest in non-invasive treatments and aesthetic enhancements. These centers often provide a more relaxed environment and cater to a clientele seeking convenience and luxury, further driving their popularity. The adaptability of spas in marketing innovative procedures positions them as key contenders in capturing the evolving preferences of cosmetic surgery consumers.

## Regional Market Share Analysis

### US : Leading Market with Diverse Offerings

The US cosmetic surgery market holds a commanding 18.0% share, valued at approximately $18 billion in 2024. Key growth drivers include increasing consumer awareness, advancements in technology, and a rising trend towards minimally invasive procedures. Regulatory support from the FDA and various state health departments has fostered a favorable environment for innovation. Additionally, robust healthcare infrastructure and a high concentration of skilled professionals contribute to the market's expansion.

### Canada : Expanding Demand for Aesthetic Procedures

Canada's cosmetic surgery market, with a 3.5% share, is valued at around $3.5 billion as of 2024. The growth is fueled by increasing disposable incomes, a shift in societal norms towards aesthetic enhancement, and a growing aging population seeking rejuvenation. Government regulations are becoming more supportive, with Health Canada ensuring safety and efficacy in cosmetic products. The market is also benefiting from improved healthcare facilities and training programs for practitioners.

## Competitive Benchmarking

The North American cosmetic surgery market is characterized by a dynamic competitive landscape, driven by a confluence of innovation, consumer demand for aesthetic enhancements, and the increasing acceptance of cosmetic procedures. Key players such as Allergan (US), Revance Therapeutics (US), and Galderma (CH) are at the forefront, each adopting distinct strategies to solidify their market positions. Allergan (US), known for its flagship product Botox, continues to focus on innovation and product diversification, while Revance Therapeutics (US) emphasizes its commitment to developing advanced neuromodulators and dermal fillers, thereby enhancing its competitive edge. Galderma (CH), on the other hand, is leveraging strategic partnerships to expand its product offerings and market reach, indicating a trend towards collaborative growth in the sector.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Allergan (US) and Galderma (CH) suggests a trend towards consolidation, as these firms seek to leverage economies of scale and enhance their competitive positioning.

In October Allergan (US) announced the launch of a new line of minimally invasive facial rejuvenation products, aimed at capturing the growing demand for non-surgical options. This strategic move not only diversifies Allergan's product portfolio but also positions the company to capitalize on the increasing consumer preference for less invasive procedures, potentially driving significant revenue growth in the coming years.

In September Revance Therapeutics (US) secured a partnership with a leading aesthetic clinic chain to expand the distribution of its innovative DaxibotulinumtoxinA injection. This collaboration is likely to enhance Revance's market penetration and brand visibility, reinforcing its position as a key player in the cosmetic surgery market. The partnership underscores the importance of strategic alliances in navigating the competitive landscape.

In August Galderma (CH) launched a sustainability initiative aimed at reducing its carbon footprint across its manufacturing processes. This initiative not only aligns with global sustainability trends but also enhances Galderma's brand reputation among environmentally conscious consumers, potentially attracting a new demographic to its product offerings.

As of November the competitive trends in the cosmetic surgery market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development and marketing strategies. Strategic alliances are playing a crucial role in shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the sophisticated demands of consumers.

## Recent News & Developments

- **Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults** Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid microdroplet injectable, for improving cheek skin smoothness in adults in the United States.
- **Q2 2024: Cutera Appoints Taylor Harris as Chief Executive Officer** Cutera, Inc., a provider of aesthetic and dermatology solutions, announced the appointment of Taylor Harris as its new Chief Executive Officer, effective May 2024.
- **Q2 2024: Revance Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia** Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its neuromodulator portfolio in the U.S. market.
- **Q1 2024: Sientra Announces FDA Approval of New Breast Implant Manufacturing Facility in Wisconsin** Sientra, Inc. received FDA approval for its new breast implant manufacturing facility in Wisconsin, aiming to increase production capacity and meet growing demand in the North American cosmetic surgery market.
- **Q1 2024: Alastin Skincare Launches New Procedure Enhancement System for Post-Cosmetic Surgery Recovery** Alastin Skincare, a Galderma company, launched a new Procedure Enhancement System designed to support post-cosmetic surgery recovery, targeting clinics and patients in North America.
- **Q2 2024: Allergan Aesthetics Launches JUVÉDERM® VOLUX™ XC for Jawline Enhancement in the U.S.** Allergan Aesthetics announced the U.S. launch of JUVÉDERM® VOLUX™ XC, a hyaluronic acid-based injectable gel for jawline enhancement, expanding its facial aesthetics portfolio.
- **Q2 2024: Cutera Launches AviClear™ Acne Device in North America** Cutera, Inc. launched AviClear™, a new energy-based device for the treatment of mild to severe acne, in North America, targeting dermatology and cosmetic surgery clinics.
- **Q1 2024: Galderma Announces U.S. FDA Approval of Restylane® Eyelight for the Treatment of Undereye Hollows** Galderma received FDA approval for Restylane® Eyelight, a hyaluronic acid filler for the treatment of undereye hollows, expanding its injectable product offerings in the U.S.
- **Q2 2024: Soliton, Inc. Announces Partnership with Aesthetic Solutions for Rapid Acoustic Pulse Technology** Soliton, Inc. entered into a partnership with Aesthetic Solutions to distribute its Rapid Acoustic Pulse technology for cellulite and tattoo removal in North America.
- **Q1 2024: Venus Concept Announces FDA Clearance of Venus Bliss Max™ for Non-Invasive Lipolysis** Venus Concept received FDA clearance for Venus Bliss Max™, a new device for non-invasive lipolysis of the abdomen and flanks, targeting cosmetic surgery providers in North America.
- **Q2 2024: InMode Ltd. Launches EmpowerRF Platform for Women’s Health and Wellness in the U.S.** InMode Ltd. launched EmpowerRF, a new platform for women’s health and wellness procedures, including minimally invasive cosmetic treatments, in the U.S. market.
- **Q1 2024: Apyx Medical Receives FDA 510(k) Clearance for Renuvion® APR Handpiece for Dermal Resurfacing** Apyx Medical Corporation received FDA 510(k) clearance for its Renuvion® APR Handpiece, expanding its portfolio of devices for dermal resurfacing procedures in the U.S.

## Report Scope

| MARKET SIZE 2024 | 21.5(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 23.15(USD Billion) |
| MARKET SIZE 2035 | 48.5(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.68% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Hugel (KR), Ipsen (FR), Medytox (KR), Sientra (US), Croma-Pharma (AT) |
| Segments Covered | Procedure Type, End User |
| Key Market Opportunities | Integration of advanced technologies enhances patient experience and expands service offerings in the cosmetic surgery market. |
| Key Market Dynamics | Rising consumer demand for minimally invasive procedures drives innovation and competition in the cosmetic surgery market. |
| Countries Covered | US, Canada |

## Frequently Asked Questions

**Q: What was the market valuation of the North America cosmetic surgery market in 2024?**
A: The market valuation was $21.5 Billion in 2024.

**Q: What is the projected market valuation for the North America cosmetic surgery market by 2035?**
A: The projected valuation for 2035 is $48.5 Billion.

**Q: What is the expected CAGR for the North America cosmetic surgery market during the forecast period 2025 - 2035?**
A: The expected CAGR is 7.68% during the forecast period 2025 - 2035.

**Q: Which segments contributed to the North America cosmetic surgery market in terms of procedure type?**
A: In 2024, the invasive segment was valued at $10.5 Billion, while the non-invasive segment was valued at $11.0 Billion.

**Q: What are the projected values for the invasive and non-invasive segments by 2035?**
A: By 2035, the invasive segment is projected to reach $23.5 Billion, and the non-invasive segment is expected to reach $25.0 Billion.

**Q: What are the key end-user segments in the North America cosmetic surgery market?**
A: The end-user segments include hospitals and dermatology clinics, ambulatory surgical centers, and others.

**Q: What was the market valuation for hospitals and dermatology clinics in 2024?**
A: In 2024, hospitals and dermatology clinics were valued at $8.6 Billion.

**Q: What is the projected market size for ambulatory surgical centers by 2035?**
A: The projected market size for ambulatory surgical centers by 2035 is $16.5 Billion.

**Q: Who are the key players in the North America cosmetic surgery market?**
A: Key players include Allergan (US), Galderma (CH), Revance Therapeutics (US), and others.

**Q: What was the market valuation for the 'Others' segment in 2024?**
A: The 'Others' segment was valued at $5.7 Billion in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/north-america-cosmetic-surgery-market-16176*